Industry

From a bold idea to a thriving biotech: a conversation with the CEO of Argenx

Behind one of Europe’s most successful biotech companies stands a story of perseverance and relentless belief in impact. As co-founder and CEO of Argenx, Tim Van Hauwermeiren has navigated the company from a bold idea with no data to global success. We asked him some questions about his career path, the realities of building a biotech company, and the lessons he believes are essential for scientists looking to move beyond academia.

Industry

From a bold idea to a thriving biotech: a conversation with the CEO of Argenx

Industry

From a bold idea to a thriving biotech: a conversation with the CEO of Argenx

Latest News

Opinion

“Zie je wel… het kan wel in Europa.”

Opinion

Maak van Nederland dé Europese biotech hub!

Innovation

How did Bio-Prodict develop the best mutation AI prediction platform in the world?

Opinion

“Zie je wel… het kan wel in Europa.”

Opinion

Maak van Nederland dé Europese biotech hub!

Innovation

How did Bio-Prodict develop the best mutation AI prediction platform in the world?

Career

From Postdoc to Biotech CEO: A Conversation with the CEO of ImmuneWatch

Career

From Postdoc to Biotech CEO: A Conversation with the CEO of ImmuneWatch

Career

From Postdoc to Biotech CEO: A Conversation with the CEO of ImmuneWatch

Career

From Postdoc to Biotech CEO: A Conversation with the CEO of ImmuneWatch

Career

Crossroads in career: True to Science, Open to Opportunity | What BioBusiness Summer School taught me about transitioning to industry

Career

Crossroads in career: True to Science, Open to Opportunity | What BioBusiness Summer School taught me about transitioning to industry

Career

Crossroads in career: True to Science, Open to Opportunity | What BioBusiness Summer School taught me about transitioning to industry

Career

Don’t Wait for Luck 🍀— Create it

Career

Don’t Wait for Luck 🍀— Create it

Career

Don’t Wait for Luck 🍀— Create it

Career

The TOPX Females to Follow Awards 2025: Celebrating Tomorrow’s Biotech Leaders

Career

The TOPX Females to Follow Awards 2025: Celebrating Tomorrow’s Biotech Leaders

Career

The TOPX Females to Follow Awards 2025: Celebrating Tomorrow’s Biotech Leaders

Career

Feb 26, 2026

From Postdoc to Biotech CEO: A Conversation with the CEO of ImmuneWatch

Jobs at BCF Career

AgoMab

Senior Clinical Trial Associate

AgoMab

Senior Clinical Trial Associate

GenDx

QC Technician (Molecular Biology)

GenDx

QC Technician (Molecular Biology)

BIRD Recruitment

HSE Supervisor (ref. 2475)

BIRD Recruitment

HSE Supervisor (ref. 2475)

Balans

Administratief Medewerker (ref. 2474)

Balans

Administratief Medewerker (ref. 2474)

BIRD Recruitment

Careers Consultant

BIRD Recruitment

Careers Consultant

TNO

Quality Integrator

TNO

Quality Integrator

AgoMab

Senior Clinical Trial Associate

GenDx

QC Technician (Molecular Biology)

BIRD Recruitment

HSE Supervisor (ref. 2475)

Balans

Administratief Medewerker (ref. 2474)

Events

Mar 26, 2026

Innovation for Health

Mar 26, 2026

Innovation for Health

May 21, 2026

BCF Career Event Netherlands - Jaarbeurs Utrecht

May 21, 2026

BCF Career Event Netherlands - Jaarbeurs Utrecht

Jun 22, 2026

BioBusiness Summer School

Jun 22, 2026

BioBusiness Summer School

Oct 7, 2026

Dutch Medicines Days

Oct 7, 2026

Dutch Medicines Days

Mar 26, 2026

Innovation for Health

May 21, 2026

BCF Career Event Netherlands - Jaarbeurs Utrecht

Jun 22, 2026

BioBusiness Summer School

Oct 7, 2026

Dutch Medicines Days

Nov 26, 2026

BCF Career Event Belgium - Flanders Expo

Contributions

Eline van Beest

“Zie je wel… het kan wel in Europa.”

Eline van Beest

“Zie je wel… het kan wel in Europa.”

Eline van Beest

“Zie je wel… het kan wel in Europa.”

Marc van Voorst tot Voorst

Maak van Nederland dé Europese biotech hub!

Marc van Voorst tot Voorst

Maak van Nederland dé Europese biotech hub!

Marc van Voorst tot Voorst

Maak van Nederland dé Europese biotech hub!

Haifen Hu

A New Chapter for BiotechNews

Haifen Hu

A New Chapter for BiotechNews

Haifen Hu

A New Chapter for BiotechNews

Sangbreeta Moitra

The 7 Steps to Unlock & Influence Change - that people most often miss

Sangbreeta Moitra

The 7 Steps to Unlock & Influence Change - that people most often miss

Sangbreeta Moitra

The 7 Steps to Unlock & Influence Change - that people most often miss

Innovation

Innovation

Feb 27, 2026

How did Bio-Prodict develop the best mutation AI prediction platform in the world?

Innovation

Tapping Into the Full Therapeutic Potential of GLP-1

Innovation

Tapping Into the Full Therapeutic Potential of GLP-1

Innovation

EfficiencyTactics: Enabling Successful AI Transformation in Life Sciences

Innovation

EfficiencyTactics: Enabling Successful AI Transformation in Life Sciences

Innovation

Bilthoven Biologicals ontvangt samen met SLS Europe positieve CHMP Opinie voor SIILTIBCY® – een nieuwe tuberculose huidtest

Innovation

Bilthoven Biologicals ontvangt samen met SLS Europe positieve CHMP Opinie voor SIILTIBCY® – een nieuwe tuberculose huidtest

Innovation

Transforming healthcare with technology: TNO innovations for a sustainable future

Innovation

Transforming healthcare with technology: TNO innovations for a sustainable future

Innovation

PEI Pandora Endocrine Innovation - Progesteron veroorzaakt borstkanker

Innovation

PEI Pandora Endocrine Innovation - Progesteron veroorzaakt borstkanker

Innovation

Tapping Into the Full Therapeutic Potential of GLP-1

Innovation

EfficiencyTactics: Enabling Successful AI Transformation in Life Sciences

Innovation

Bilthoven Biologicals ontvangt samen met SLS Europe positieve CHMP Opinie voor SIILTIBCY® – een nieuwe tuberculose huidtest

Industry

Industry

Moderna - Ten strijde tegen infectieziekten

Industry

Moderna - Ten strijde tegen infectieziekten

Industry

Moderna - Ten strijde tegen infectieziekten

Industry

Flerie takes a different approach to investing in biotechnology - Ted Fjällman, CEO of investment company Flerie, talks about the biotechnology investment firm's strategy

Industry

Flerie takes a different approach to investing in biotechnology - Ted Fjällman, CEO of investment company Flerie, talks about the biotechnology investment firm's strategy

Industry

Flerie takes a different approach to investing in biotechnology - Ted Fjällman, CEO of investment company Flerie, talks about the biotechnology investment firm's strategy

Partnerships

A new collaboration between MK Bio Consultancy and AMK Compliance Insight

Partnerships

A new collaboration between MK Bio Consultancy and AMK Compliance Insight

Partnerships

A new collaboration between MK Bio Consultancy and AMK Compliance Insight

Partnerships

Biotech Booster succesvolle Bruggenbouwer

Partnerships

Biotech Booster succesvolle Bruggenbouwer

Partnerships

Biotech Booster succesvolle Bruggenbouwer

Ecosystem

Zorg en bedrijven versterken health-innovatie in Noord-Nederland

Ecosystem

Zorg en bedrijven versterken health-innovatie in Noord-Nederland

Ecosystem

Zorg en bedrijven versterken health-innovatie in Noord-Nederland

Ecosystem

Eli Lilly chooses Leiden Bio Science Park for major expansion, boosting the Netherlands’ life-sciences ecosystem

Ecosystem

Eli Lilly chooses Leiden Bio Science Park for major expansion, boosting the Netherlands’ life-sciences ecosystem

Ecosystem

Eli Lilly chooses Leiden Bio Science Park for major expansion, boosting the Netherlands’ life-sciences ecosystem

Opinion

“Zie je wel… het kan wel in Europa.”

Opinion

“Zie je wel… het kan wel in Europa.”

Opinion

“Zie je wel… het kan wel in Europa.”

Opinion

Maak van Nederland dé Europese biotech hub!

Opinion

Maak van Nederland dé Europese biotech hub!

Opinion

Maak van Nederland dé Europese biotech hub!

Startups

Startup

From Science to Startups: A Conversation with the Head of New Ventures at VIB

Startup

From Science to Startups: A Conversation with the Head of New Ventures at VIB

Startup

MimeCure: Van die-hard-science naar business: een steile leercurve

Startup

MimeCure: Van die-hard-science naar business: een steile leercurve

Startup

From farm to fermentation: Aisling Foley and the ExCulture team’s vision for changing the way heparin is produced

Startup

From farm to fermentation: Aisling Foley and the ExCulture team’s vision for changing the way heparin is produced

Startup

VirXcel: Targeting Respiratory Viruses with Macrocyclic Peptides

Startup

VirXcel: Targeting Respiratory Viruses with Macrocyclic Peptides

Startup

From Science to Startups: A Conversation with the Head of New Ventures at VIB

Startup

MimeCure: Van die-hard-science naar business: een steile leercurve

Startup

From farm to fermentation: Aisling Foley and the ExCulture team’s vision for changing the way heparin is produced

Startup

VirXcel: Targeting Respiratory Viruses with Macrocyclic Peptides

Startup

Start-up Excellence on Stage - Meet the 9 Finalists of Health~Holland Global Investor Forum 2025

Startup

Curie Capital - Enabling life sciences companies to bring scientific innovation to patients

Podcast

Dimitri de Vreeze

Mar 6, 2026

Dimitri de Vreeze is CEO van DSM-Firmenich.

Leaders in Life Sciences: Dé podcast over leiders in Life Sciences.

Carla Hollak

Carla Hollak is hoogleraar Medicijnen en Maatschappij aan het UMC Amsterdam en Chair van RARE-NL

Sander van Asbeck

Sander van Asbeck is CEO en co-founder van Ribopro, een bedrijf dat zich richt op mRNA

Ruth Peetoom

Ruth Peetoom is voorzitter van de Nederlandse GGZ

Podcast

Dimitri de Vreeze

Mar 6, 2026

Dimitri de Vreeze is CEO van DSM-Firmenich.

Leaders in Life Sciences: Dé podcast over leiders in Life Sciences.

Carla Hollak

Carla Hollak is hoogleraar Medicijnen en Maatschappij aan het UMC Amsterdam en Chair van RARE-NL

Sander van Asbeck

Sander van Asbeck is CEO en co-founder van Ribopro, een bedrijf dat zich richt op mRNA

Ruth Peetoom

Ruth Peetoom is voorzitter van de Nederlandse GGZ

Podcast

Dimitri de Vreeze

Mar 6, 2026

Dimitri de Vreeze is CEO van DSM-Firmenich.

Leaders in Life Sciences: Dé podcast over leiders in Life Sciences.

Carla Hollak

Carla Hollak is hoogleraar Medicijnen en Maatschappij aan het UMC Amsterdam en Chair van RARE-NL

Sander van Asbeck

Sander van Asbeck is CEO en co-founder van Ribopro, een bedrijf dat zich richt op mRNA

From a bold idea to a thriving biotech: a conversation with the CEO of Argenx

From a bold idea to a thriving biotech: a conversation with the CEO of Argenx

From a bold idea to a thriving biotech: a conversation with the CEO of Argenx

Top stories

Top stories

Eli Lilly chooses Leiden Bio Science Park for major expansion, boosting the Netherlands’ life-sciences ecosystem

Latest News

Career

Career

From Postdoc to Biotech CEO: A Conversation with the CEO of ImmuneWatch

Jobs at BCF Career

Events

Events

Contributions

Innovation

How did Bio-Prodict develop the best mutation AI prediction platform in the world?

Industry

Industry

Partnerships

Partnerships

Ecosystem

Ecosystem

Opinion

Opinion

Startups

Startups

Podcast

Dimitri de Vreeze is CEO van DSM-Firmenich.

Podcast

Dimitri de Vreeze is CEO van DSM-Firmenich.

Podcast

Dimitri de Vreeze is CEO van DSM-Firmenich.

Sections

BiotechNews

Sections

BiotechNews

Sections

BiotechNews